Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, March 23, 2016
Vetter, a global contract development and manufacturing organization (CDMO) for the development, commercial manufacturing and final packaging of aseptically prefilled drug-delivery systems, has announced the construction of a new building at a ground...
read more
Thursday, January 18, 2024
Vetter has joined the German Association of Research-Based Pharmaceutical Companies (vfa) as an associate member. With this membership, the vfa recognizes the significant role that the pharmaceutical service provider plays in the field of complex ...
read more
Wednesday, November 12, 2014
Vetter, a leading
contract development and manufacturing organization (CDMO), today officially announced
a series of adjustments to its Development Service related structures designed to support
its customer base. Effective October 1, Dr. Susanne ...
read more
Friday, November 21, 2014
Vetter, a global leader in the aseptic fill and finish of
injection systems, servicing the top-ten pharm/biotech companies worldwide along with
mid-size firms and emerging startups, today announced the opening of a new
representative office in ...
read more
Tuesday, October 17, 2023
Vetter has announced additional investments as part of its long-term dedication to customer partnerships. Vetter’s extensive 40+ years of experience in aseptic filling and packaging shows a consistent desire for sustainable growth and corporate ...
read more
Rentschler Biopharma and Vetter, two globally operating Contract Development and Manufacturing Organizations (CDMOs), announced that their strategic collaboration has taken key steps forward.
read more
Thursday, January 15, 2026
Vetter has reached several milestones in the development of its next-generation tamper-evident syringe closure system, V-OVS® next, moving the product closer to commercial launch in 2027.
read more
Tuesday, December 02, 2014
Vetter has announced a major milestone in the issue of drug safety. The contract development and manufacturing organization (CDMO) now offers the option of clearly identifying packaging used for drugs. Vetter's comprehensive and flexible ...
read more
Tuesday, September 10, 2013
Theorem Clinical Research has promoted veteran U.K. researcher Phil Lake to head its biopharmaceutical franchise in respiratory. As executive director of biopharmaceutical development, respiratory, Lake will be responsible for senior oversight on ...
read more
Friday, November 22, 2019
Vertex and Molecular Templates have entered into a research collaboration to discover and develop novel targeted conditioning regimens that may enhance the hematopoietic stem cell transplant process.
read more
Thursday, October 24, 2019
Vertex announced an access agreement with NHS England for all currently licensed Vertex cystic fibrosis medicines and any future indications of these medicines.
read more
Vertex Pharmaceuticals Incorporated and Modena Therapeutics have entered into an exclusive research collaboration and licensing agreement aimed at the discovery and development of messenger Ribonucleic Acid (mRNA) Therapeutics™ for the treatment of ...
read more
Wednesday, September 25, 2019
Versatope Therapeutics has been awarded a contract with NIAID, a division of the National Institutes of Health (NIH), worth up to $17.9M over five years.
read more
Thursday, January 05, 2023
Verrica Pharmaceuticals Inc. announced the successful completion of the technology transfer of bulk solution manufacturing to Piramal Pharma Solutions.
read more
Veristat has entered into a Preferred Provider Agreement with AOBiome.
read more